Skip to main content

CORRECTION article

Front. Mol. Biosci., 08 October 2024
Sec. Molecular Diagnostics and Therapeutics
Volume 11 - 2024 | https://doi.org/10.3389/fmolb.2024.1497296

Corrigendum: Comprehensive analysis of the prognostic and immunological role of PAFAH1B in pan-cancer

This article is a correction to:

  1. Comprehensive Analysis of the Prognostic and Immunological Role of PAFAH1B in Pan-Cancer

    1. Read original article
Yixiao Yuan&#x;Yixiao Yuan1†Xiulin Jiang&#x;Xiulin Jiang2†Lin Tang&#x;Lin Tang1†Juan WangJuan Wang1Lincan Duan Lincan Duan1*
  • 1Department of Thoracic Surgery, The Third Affiliated Hospital of Kunming Medical University, Kunming, China
  • 2Key Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences and Yunnan Province, Kunming Institute of Zoology, Kunming, China

A Corrigendum on
Comprehensive analysis of the prognostic and immunological role of PAFAH1B in pan-cancer

by Yuan Y, Jiang X, Tang L, Wang J and Duan L (2022). Front. Mol. Biosci. 8:799497. doi: 10.3389/fmolb.2021.799497

In the published article, there was an error in Figure 12 as published. The representative pictures of transwell, SMCC-7721 cells in Figure 12G were presented incorrectly. The corrected Figure 12 and its caption appear below.

Figure 12
www.frontiersin.org

Figure 12. Knockdown of PAFAH1B3 inhibits LIHC progression. (A) The expression PAFAH1B3 in LIHC cells lines was examined by qRT-PCR assay. (B) Establishment of PAFAH1B3 knockdown cell lines in SMC-7721 and Hu7 verified by qRT-PCR assay. (C) Knockdown of PAFAH1B3 dramatically inhibits SMC-7721 and Hu7 cells proliferation examined by growth curve assay. (D, E) Knockdown of PAFAH1B3 dramatically inhibits SMC-7721 and Hu7 cells colony formation ability. (F, G) Knockdown of PAFAH1B3 dramatically inhibits SMC-7721 and Hu7 cells migration and invasion abilities.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: PAFAH1B3, pan-cancer, immune cell infiltration, drug sensitivity, prognostic biomarker, multi-omics integrative analysis, cell proliferation, cell migration

Citation: Yuan Y, Jiang X, Tang L, Wang J and Duan L (2024) Corrigendum: Comprehensive analysis of the prognostic and immunological role of PAFAH1B in pan-cancer. Front. Mol. Biosci. 11:1497296. doi: 10.3389/fmolb.2024.1497296

Received: 16 September 2024; Accepted: 27 September 2024;
Published: 08 October 2024.

Edited and reviewed by:

Matteo Becatti, University of Firenze, Italy

Copyright © 2024 Yuan, Jiang, Tang, Wang and Duan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Lincan Duan, duanmumuhuosan@163.com

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.